Brief: Biocept Signs CNSide Licensing Agreement With Plus Therapeutics

Biocept

08/09/2023 14:53

Sept 8 (Reuters) - Biocept Inc  BIOC.O :
    * BIOCEPT SIGNS CNSIDE™ LICENSING AGREEMENT WITH PLUS
THERAPEUTICS
    * BIOCEPT INC - NEW AGREEMENT ALLOWS FOR PLUS TO PERFORM
CNSIDE
TESTING DURING ITS CLINICAL TRIALS AND COMMERCIALLY, SUBJECT TO
REGULATORY APPROVAL

Source text for Eikon:  ID:nBw8F2GnPa 
Further company coverage:  BIOC.O 

 ((Reuters.Briefs@thomsonreuters.com;))